H.C. Wainwright reiterates Ionis stock rating on hepatitis B data

H.C. Wainwright reiterates Ionis stock rating on hepatitis B data

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.